SCHEMBL574968

SCHEMBL574968

NC[S]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL531147 0.72
SCHEMBL3975001 0.61
SCHEMBL63975 0.61
SCHEMBL127813 0.61
Propylamine SCHEMBL448871 0.58
Propylamine SCHEMBL1330797 0.58
Water SCHEMBL8782173 0.55
Water SCHEMBL16713419 0.55
SCHEMBL23961 0.55
Ethylenediamine SCHEMBL7085968 0.55 NFKB1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497494-C Discoloration prevention in pyrithione-containing coating compositions ARCH CHEM INC (US) 2009-06-10 CN claimed
CN-1624055-A Discoloration prevention in pyrithione-containing coating compositions ARCH CHEM INC (US) 2005-06-08 CN claimed
US-4952690-A 6-substituted thia-aza compounds CIBA-GEIGY CORPORATION (US) 1990-08-28 US claimed
EP-0018063-B1 PYRIDAZIN (2H)-3-ONES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN ANTIHYPERTENSIVE AGENTS DIAMOND SHAMROCK CORPORATION (US) 1983-02-23 EP claimed
US-3976641-A Cephalosporin intermediates and process therefor SMITHKLINE CORPORATION (US) 1976-08-24 US claimed
CN-118165062-A Synthesis method and application of one-pot method for synthesizing dicyclo-stapler peptide in one-pot method 河北大学 2024-06-11 CN disclosed
EP-2657227-B1 NOVEL SUBSTITUTED ISOQUINOLINE DERIVATIVE WESTERN THERAPEUTICS INST INC D (JP) 2016-04-27 EP disclosed
CN-102448941-B The isoquinilone derivatives replaced D. WESTERN THERAPEUTICS INSTITUTE, INC. (JP) 2016-04-06 CN disclosed
EP-2444395-B1 SUBSTITUTED ISOQUINOLINE DERIVATIVE WESTERN THERAPEUTICS INST INC D (JP) 2016-01-06 EP disclosed
US-8951997-B2 Substituted isoquinoline derivative D. WESTERN THERAPEUTICS INSTITUTE, INC. (JP) 2015-02-10 US disclosed
US-8883792-B2 Substituted isoquinoline derivative D. WESTERN THERAPEUTICS INSTITUTE, INC. (JP) 2014-11-11 US disclosed
EP-2657227-A1 NOVEL SUBSTITUTED ISOQUINOLINE DERIVATIVE D. Western Therapeutics Institute, Inc. (JP) 2013-10-30 EP disclosed
US-4394384-A ANTIBIOTICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-07-19 US disclosed
EP-0003960-B1 6-SUBSTITUTED THIA-AZA-COMPOUNDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM CIBA-GEIGY AG (CH) 1983-06-29 EP disclosed
EP-0069378-A2 Antibacterial penem derivatives HOECHST UK LIMITED (GB) 1983-01-12 EP disclosed
US-4331676-A 2-PENEM COMPOUNDS UNSUBSTITUTED IN THE 6 POSITION CIBA-GEIGY CORPORATION (US) 1982-05-25 US disclosed
EP-0042026-A1 3,4-Disubstituted azetidin-2-on compounds and process for their preparation CIBA-GEIGY AG (CH) 1981-12-23 EP disclosed
EP-0041768-A2 Beta-lactam compounds, their preparation and use BEECHAM GROUP PLC (GB) 1981-12-16 EP disclosed
EP-0025199-A2 Cephem compounds, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-03-18 EP disclosed
EP-0003960-A1 6-Substituted thia-aza-compounds, their preparation and pharmaceutical compositions containing them CIBA-GEIGY AG (CH) 1979-09-19 EP disclosed